《中药生产监督管理专门规定》是我国首部系统规范中药生产监管的专门规范性文件，标志着中药生产监管由通用要求向体现中药生产特点的专门制度进一步深化，有助于提升中药生产规范化水平和质量稳定性，推动监管方式现代化，为构建符合中药特点的药品监管体系、促进中药产业高质量发展提供制度支撑。该规定立足中药原料天然属性强、质量形成链条长、影响因素复杂等特点，围绕中药材源头控制、生产过程管理、检验放行、追溯体系、药物警戒和监督管理等关键环节，构建了覆盖中药生产全过程的监管框架。其制度设计突出遵循中药规律，强化药品上市许可持有人主体责任，强调源头治理、过程严控和风险分级监管，并对原料均一化处理、提取收率管理、委托生产、恢复生产和中药注射剂监管等重点问题作出具体要求。通过对出台背景、制度逻辑、主要内容、关键创新及实施路径等方面进行分析，助力业界对该规定实施的意义有更深刻的理解。

The “Special Provisions for the Supervision and Administration of Traditional Chinese Medicine Production” is China’s first regulatory document specifically designed to systematically regulate the oversight of traditional Chinese medicine (TCM) production. It signifies a deepening shift from general requirements to a specialized system that reflects the unique characteristics of TCM manufacturing. This development helps to enhance the standardization of TCM production and the stability of its quality, modernize regulatory approaches, and provide institutional support for building a drug regulation system tailored to TCM’s features, thereby promoting the high-quality development of the TCM industry. Grounded in the inherent characteristics of TCM-such as the natural origin of its raw materials, long quality formation chains, and complex influencing factors-the provisions establish a regulatory framework covering the entire TCM production lifecycle. This framework addresses key areas including source control of Chinese medicinal materials, production process management, testing and release, traceability systems, pharmacovigilance, and regulatory oversight. The institutional design emphasizes adherence to TCM principles, strengthens the subject responsibility of the marketing authorization holder, highlights source control, rigorous process management, and risk-based classification supervision. Furthermore, it provides detailed requirements for critical issues such as raw material homogenization, extract yield management, contract manufacturing, production resumption, and the oversight of TCM injections. By analyzing the background of its issuance, institutional logic, main content, key innovations, and implementation pathways, this paper aims to facilitate a deeper understanding of the significance of implementing these Special Provisions among the industry.

R28